Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Miami, Florida.

Pulse Biosciences Inc

An update from Pulse Biosciences ( ($PLSE) ) is now available. On April 8, 2026, Pulse Biosciences appointed medical technology veteran Liane R. Te...

Pulse Biosciences appoints new COO to advance commercialization

Pulse Biosciences ( ($PLSE) ) has provided an announcement. On April 7, 2026 Pulse Biosciences announced it had enrolled and treated the first seve...

Pulse Biosciences Launches Pivotal NANOPULSE-AF Clinical Study

Pulse Biosciences ( ($PLSE) ) has provided an update. On March 23, 2026, Pulse Biosciences, Inc. granted its Chief Technology Officer, Darrin R. Ue...

Pulse Biosciences Grants RSUs to Chief Technology Officer

Pulse Biosciences ( ($PLSE) ) has shared an announcement. On March 12, 2026, Pulse Biosciences announced that the first patients were enrolled in a...

Market Cap	$1.18B	P/E Ratio	N/A
52W High	$26.30	52W Low	$12.56
Div Yield	N/A	Payout Ratio	N/A
EPS Growth 3Y	0.0%	52W Position	48.7%
Overall Score	42	Value Score	40
Quality Score	23	Technical Score	63

EPS Current Est	$-1.51	EPS Next Est	$-1.7
EPS Growth Est	N/A	DPS Growth 3Y	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	PLSE	$19.25	0.00%	169.49K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	PLSE	$19.25	0%	169.49K
3
4
5
6

PLSE

PLSE

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get Pulse Biosciences Inc Data in Excel

Get Pulse Biosciences Inc Data in Excel